Summary
The effects of terfenadine and pseudoephedrine, alone and in combination, have been assessed in a nasal provocation test and in perennial rhinitis.
In a double-blind, placebo-controlled cross-over nasal provocation test, twelve men allergic to grass pollen were treated with two daily doses of placebo, terfenadine 60 mg, pseudoephedrine 120 mg, or the combination of the two, for 2 days preceding each test. The allergic reaction threshold, based on rhinorrhoea, sneezing and nasal inspiratory peak flow rate, was raised significantly both by terfenadine and pseudoephedrine, and their effects appeared additive (repeated measures analysis of variance).
In a double-blind, randomized clinical study of perennial rhinitis two parallel groups, the efficacy and tolerability of terfenadine and terfenadine-pseudoephedrine were compared in 50 patients. Symptoms and signs in both groups were improved after 14 days of treatment. Differences between groups showed a trend in favour of terfenadine-pseudoephedrine, for swelling of the nasal mucosa (rhinoscopy) they were statistically significant. Both medications were well tolerated overall, although adverse events and reactions were more frequent in the terfenadine-pseudoepherine group.
In conclusion, terfenadine-pseudoephedrine and its constituents taken alone were effective. The combination performed better, but adverse events were somewhat more frequent with the combination than with terfenadine alone.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Sorkin EM, Heel RC (1985) Terfenadine. A review of its pharmacodynamic properties and therapeutic efficacy. Drugs 29: 34–56
Food and Drug Administration (1985) Tentative final monograph for OTC antihistamine products. Fed Reg 50: 2219–2241
Food and Drug Administration (1988) Proposed rules. Fed Reg 53: 30522–30564
Morgan JP (1987) Over the counter availability of sympathomimetics. Br Med J 295: 924
Whitehouse A (1987) Over the counter availability of sympathomimetics. Br Med J 294: 1308
Whitehouse A (1987) Over the counter availability of sympathomimetics. Br Med J 295: 924
Nicholson AN, Stone BM (1986) Antihistamines: Impaired Performance and the Tendency to Sleep. Eur J Clin Pharmacol 30: 27–32
O'Hanlon JF (1988) Antihistamines and Driving Safety. Cutis 42(4A): 10–13
Kolly M, Pecoud A (1986) Comparison of levocabastine, a new selective H1-receptor antagonist, and disodium cromoglycate, in a nasal provocation test with allergen. Br J Clin Pharmacol 22: 389–394
Empey DW, Bye C, Hodder M, Hughes DTD (1975) A double-blind crossover trial of pseudoephedrine and triprolidine, alone and in combination, for the treatment of allergic rhinitis. Ann Allergy 34: 41–46
Empey DW, Young GA, Letley E, John GC, Smith P, McDonnell KA, Bagg LR, Hughes DTD (1980) Dose-response study of the nasal-decongestant and cardiovascular effects of pseudoephedrine. Br J Clin Pharmacol 9: 351–358
Connell JT, Williams BO, Allen S, Cato A, Perkins JG (1982) A double-blind controlled evaluation of Actifed and its individual constituents in allergic rhinitis. J Int Med Res 10: 341–347
Cohen BM (1975) Physiologic/clinical comparisons of a sustained-release decongestant combination, its components and placebo in patients with allergic rhinitis. J Asthma Res 13: 7–13
Empey DW, Frosolono MF, Hughes DT, Perkins JG (1984) Comparison of pseudoephedrine and triprolidine, alone and in combination in preventing nasal congestion in subjects with allergic rhinitis using nasal histamine challenge. Br J Clin Pharmacol 18: 86–89
Diamond L, Gerson K, Cato A, Peace K, Perkins J (1981) An evaluation of triprolidine and pseudoephedrine in the treatment of allergic rhinitis. Ann Allergy 47: 87–91
Falliers CJ, Redding MA (1980) Controlled comparison of a new antihistamine-decongestant combination to its individual components. Ann Allergy 45: 75–80
Backhouse CI, Brewster BS, Lockhart JDF, Maneksha S, Purvis CR, Valle-Jones JC (1982) Terfenadine in allergic rhinitis. A comparative trial of a new antihistamine versus chlorpheniramine and placebo. Practitioner 226: 347–351
Boland N (1988) A double-blind study of astemizole and terfenadine in the treatment of perennial rhinitis. Ann Allergy 61: 18–24
Stroh Jr. ER, Ayers GH, Bernstein IL, Kemp JP, Podleski WK, Prenner BM, Schoenwetter WF, Salzmann JK (1988) A comparative tolerance study of terfenadine-pseudoephedrine combination tablets and pseudoephedrine tablets in patients with allergic or vasomotor rhinitis. J Int Med Res 16: 420–427
Dickerson J, Perrier D, Mayersohn M, Bressler R (1987) Dose tolerance and pharmacokinetic studies of L (+) pseudoephedrine capsules in man. Eur J Clin Pharmacol 14: 253–259
Porta M, Hershel J, Habankangas JAS (1986) Follow-up study of pseudoephedrine users. Ann Allergy 57: 340–342
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Henauer, S., Seppey, M., Huguenot, C. et al. Effects of terfenadine and pseudoephedrine, alone and in combination in a nasal provocation test and in perennial rhinitis. Eur J Clin Pharmacol 41, 321–324 (1991). https://doi.org/10.1007/BF00314960
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00314960